A trial comparing 2 combinations of chemotherapy for bowel cancer (FOXTROT 3)
This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.
This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.
This trial is looking at chemotherapy before surgery for bowel cancer to improve treatment.
This trial is looking at biomarkers to see if more people could benefit from cetuximab and panitumumab.
This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.
This trial is looking at the need to treat the lymph glands in the armpit after having chemotherapy followed by surgery for breast cancer.
This study is open to people who are newly diagnosed with B cell or T cell acute lymphoblastic leukaemia (ALL) and haven’t started treatment.
The trial was for people with advanced cancer who were going to have chemotherapy or other cancer treatment, and who had cachexia.
This trial is looking at treatment for a type of acute myeloid leukaemia called acute promyelocytic leukaemia (APL).
This trial compared 1 week of radiotherapy with 3 weeks of radiotherapy after surgery for breast cancer.
This trial is comparing ibrutinib alongside rituximab with fludarabine, cyclophosphamide, rituximab and venetoclax for chronic lymphocytic leukaemia.